TAS-108

A synthetic, antiestrogenic steroidal compound with potential antitumor activity. TAS-108 binds to and inhibits estrogenic receptor alpha (ERa), mainly expressed in the mammary gland and uterus and upregulated in estrogen-dependent tumors. Blockage of ERa by TAS-108 prevents the binding and effects of estrogen and may lead to an inhibition of estrogen-dependent cancer cell proliferation. TAS-108 also is a partial agonist of the estrogenic receptor beta (ERb), expressed in many tissues including the central nervous system, urogenital tract, bone and cardiovascular system, thereby exerting a positive effect on these tissues. In addition, TAS-108 activates the co-repressor Silencing Mediator for Retinoid and Thyroid hormone receptor (SMRT), a protein that inhibits the activities of the estrogen receptors, which may contribute to the antitumor activity of TAS-108. (NCI Thesaurus)

YOU MAY ALSO LIKE

TAS-103

A quinoline derivative that inhibits both topoisomerase I and II, causing a cytotoxic effect in cancer cells.

Tarvacin

A substance being studied in the treatment of several types of cancer and infections caused by certain viruses. It binds to substances…

Tartrate-Resistant Acid Phosphatase Type 5b

Tartrate-resistant acid phosphatase type 5b (325 aa, ~37 kDa) is encoded by the human ACP5 gene. This protein is involved in acid…

Tartrate-Resistant Acid Phosphatase Type 5

Tartrate-resistant acid phosphatase type 5 (325 aa, ~37 kDa) is encoded by the human ACP5 gene. This protein plays a role in…

Tartaric Acid

A white crystalline dicarboxylic acid found in many plants, particularly tamarinds and grapes. Tartaric acid is used to generate carbon dioxide through…

Tarsus Bone

Any one of the seven bones forming the instep of the foot.